4//SEC Filing
RUDNICK SETH 4
Accession 0001562180-21-004395
CIK 0001560241other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:06 PM ET
Size
12.2 KB
Accession
0001562180-21-004395
Insider Transaction Report
Form 4
RUDNICK SETH
Director
Transactions
- Award
Common Stock
2021-06-17+4,389→ 4,389 total - Award
Stock Options (Right to Buy)
2021-06-17+19,620→ 19,620 totalExercise: $21.97Exp: 2031-06-17→ Common Stock (19,620 underlying)
Holdings
- 5,266(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 17, 2021, subject to the Reporting Person's continued service as a director.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock
- [F3]These shares are held in the Seth A. Rudnick 2014 GST Trust U/A Dated 03/01/2014 (the "Trust") for the benefit of the Reporting Person's heirs. The Reporting Person's spouse is trustee of the Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F4]The shares underlying this option will vest in their entirety twelve months after June 17, 2021, subject to the Reporting Person's continued service as a director.
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeother
Related Parties
1- filerCIK 0001184420
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:06 PM ET
- Size
- 12.2 KB